Maccura Biotechnology Co., Ltd. logo

Maccura Biotechnology Co., Ltd. (300463)

Market Closed
7 Aug, 06:57
XSHE XSHE
¥
9. 35
+0.29
+3.2009%
¥
7B Market Cap
- P/E Ratio
0.42% Div Yield
9.93M Volume
- Eps
¥ 9.06
Previous Close
Add Transaction
Day Range
9 9.35
Year Range
7.87 14.2
Want to track 300463 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300463 closed Friday higher at ¥9.35, an increase of 3.2009% from Thursday's close, completing a monthly increase of 13.3333% or ¥1.1. Over the past 12 months, 300463 stock lost -16.8149%.
300463 is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0071%, based on the last three reports.
Maccura Biotechnology Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jun 08, 2016.
The company's stock is traded on one exchange.

300463 Chart

People also search for

Yangling Metron New Materials Co., Ltd.
¥ 17.3
-0.403%
Xi'an Sinofuse Electric Co., Ltd.
¥ 89.81
+2.9577%
Guangzhou Sie Consulting Co. Ltd.
¥ 27.31
+0.2202%
Zhejiang Tiantie Industry Co., Ltd.
¥ 5.16
+1.7751%
Keli Motor Group Co., Ltd.
¥ 9.66
-0.3096%

Maccura Biotechnology Co., Ltd. (300463) FAQ

What is the stock price today?

The current price is ¥9.35.

On which exchange is it traded?

Maccura Biotechnology Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300463.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.42%.

What is its market cap?

As of today, the market cap is 7B.

Has Maccura Biotechnology Co., Ltd. ever had a stock split?

Maccura Biotechnology Co., Ltd. had 1 splits and the recent split was on Jun 08, 2016.

Maccura Biotechnology Co., Ltd. Profile

Professional Services Industry
Industrials Sector
Mr. Wu Mingjian CEO
XSHE Exchange
CNE1000020H3 ISIN
CN Country
3,472 Employees
28 May 2025 Last Dividend
8 Jun 2016 Last Split
- IPO Date

Overview

Maccura Biotechnology Co.Ltd is an innovator and manufacturer in the In Vitro Diagnostics (IVD) industry, operating on a global scale. Since its inception in 1994, the company has been dedicated to the research, development, manufacturing, and sale of IVD products, serving both Chinese and international markets. Based in Chengdu, China, Maccura Biotechnology maintains a steadfast commitment to advancing medical diagnostics through its comprehensive product offerings and services, contributing to the global healthcare industry's ability to combat various diseases, including the recent COVID-19 pandemic.

Products and Services

Maccura Biotechnology Co.Ltd provides a wide range of IVD products and related services, categorized as follows:

  • Immunoassay Products: Including chemiluminescence analyzers and reagents, these tools are essential for detecting antigens or antibodies in diverse samples, aiding in the diagnosis of various conditions through immunological methods.
  • Clinical Chemistry Reagents: These are used for biochemical analysis covering areas such as hepatic function, glycometabolism, iron metabolism, renal function, coagulation, special proteins, cardiac markers, and lipids, facilitating broad spectrum disease diagnosis and monitoring.
  • Clinical Laboratory Products: This category includes automatic hematology analyzers and both automatic and semi-automatic coagulation analyzers, critical for performing complete blood counts and blood coagulation testing respectively.
  • SARS-COV-2(COVID-19) Products: To tackle the COVID-19 pandemic, Maccura offers nucleic acid detection kits among other products specifically designed for the quick and accurate detection of the COVID-19 virus.
  • Glucometers: These devices are instrumental in monitoring blood glucose levels, essential for the management and treatment of diabetes.
  • POCT Products: The Point-Of-Care Testing (POCT) lineup, including fluorescence immunoassay analyzers and colloidal gold kits, allows for immediate clinical diagnostic results at or near the site of patient care.
  • Molecular Diagnosis Products: Featuring Polymerase Chain Reaction (PCR) kits, these products enable the detection of DNA or RNA sequences, playing a crucial role in identifying various pathogens and genetic conditions.
  • Pathology Products: Aimed at histopathology laboratories, these products include equipment and reagents for tissue preparation, staining, and examination, vital for diagnosing diseases at the cellular level.

Contact Information

Address: Hi-tech Zone, Chengdu, China, 611730
Phone: 86 28 8173 1888